Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | 941061 | IM / LA |
Patient came in for a HPV9 (Gardasil 9) vaccine but received a HepB (Heplisav-b) vaccine instead. The patient did not have any side effects or symptoms. This was discovered when the patient came in for their physical on 4/16/25.
none
Bunion, gender dysphoria, anxiety, menstrual migraine
none
none
none